Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Antitumor and antiviral distamycin derivatives from Pharmacia & Upjohn

Jan. 28, 1998

PKC modulators for proliferative disorders described by Georgetown U.

Jan. 28, 1998

Mentor obtains marketing rights to new cancer therapeutic from Intracel

Jan. 27, 1998

First pivotal trial of lisofylline completed

Jan. 27, 1998

Protein farnesyltransferase inhibitors patented by Pfizer for cancer

Jan. 27, 1998

Resistance modulators for use in cancer and malaria developed at Lilly

Jan. 27, 1998

Theratechnologies' novel cancer treatment granted additional patent protection

Jan. 26, 1998

Imidazoles for reversing MDR prepared at Ontogen

Jan. 26, 1998

Clinical results reported for Servier's MDR-reversing agent S-9788

Jan. 23, 1998

Ontogen describes novel MDR modulators

Jan. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...